MedPath

The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients

Not Applicable
Recruiting
Conditions
Indigestion
Morality
Organ Failure, Multiple
Delayed Gastric Emptying
Respiratory Failure
Interventions
Other: Routine ICU care
Other: historical Routine ICU care
Other: traditional Chinese medicine
Registration Number
NCT06452966
Lead Sponsor
China Medical University Hospital
Brief Summary

Critically ill patients are at risk of or suffering from one or more key organs or organ system failure. This study will measure the effect of traditional Chinese medicine(TCM) interventions on critically ill patients admitted to the intensive care unit (ICU).

The goal of this clinical trial is to learn if traditional Chinese medicine(TCM) is effective for prevention and treatment of organ failure in ICU patients. Patients in this group will receive intervention for 2 weeks.

A multi-center non-randomized real word data study, will include 3 groups: intervention group (TCM)(n=70), control group and historical control group (admitted to the same ICU in the period of 01.2019 to 12.2023).

Main outcomes include sequential organ failure assessment (SOFA) score, ICU length of stay, hospital length of stay, number of days of respirator uses and western medicine medication used study follow up will be 2 weeks.

Detailed Description

Critically ill patients are at risk of or suffering from one or more key organs or organ system failure. This study will measure the effect of traditional Chinese medicine(TCM) interventions on critically ill patients admitted to the intensive care unit (ICU).

A multi center non-randomized real word data study, will include 3 groups: intervention group (n=70), control group (patients recruited enrolled to the ICU during the study period) and historical control group (admitted to the same ICU in the period of 01.2019 to 12.2023). The intervention group will receive traditional Chinese herbal medicine and/or acupuncture and/or low level laser applied on acupuncture points depending on TCM doctor decision and patient TCM diagnosis. Intervention period will be 2 weeks.

Main outcomes include sequential organ failure assessment (SOFA) score, ICU length of stay, hospital length of stay, number of days of respirator uses and western medicine medication used study follow up will be 2 weeks.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
350
Inclusion Criteria
  • Age 20 and above
  • Surgical ICU patients
  • The use of Chinese medicine must be approved by the attending physician in the surgical intensive care unit

Exclusion criteria:

  • Patients' family members refuse TCM intervention
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
control groupRoutine ICU carethe patients in this group will receive routine ICU care. the patients will be recruted during the study period. the patients will not recive TCM intervantions.
Historical controlhistorical Routine ICU carePatients admitted to the same ICU in the period of 01.2019 to 12.2023. the patients did not recivied TCM intervantions
intervention grouptraditional Chinese medicinepatients in the group will recived one of or a combination of the following intervantions: 1. Oral Chinese medicine decoction: The Chinese medicine practitioner will personally examine the patient and judge the patient's condition through the four diagnostic methods of traditional Chinese medicine(TCM): sight, smell, inquiry, and incision. Based on the syndrome differentiation and treatment of the patient's condition, he or she will prescribe an oral Chinese herbal decoction, two to three times a day, for two weeks. 2. Acupuncture or low level laser acupuncture treatment: Chinese medicine practitioners select acupuncture points for treatment based on the patient's condition and treat them twice a week for 20 minutes each time for a total of two weeks. the intervantion depents on the TCM doctor decision based on the patient's diagnosis and needs. in addition, the patients will recive ICU care and medication based on patient's needs.
Primary Outcome Measures
NameTimeMethod
hospital length of stay"through study completion, an average of 3 months".

The number of days a patient stays in the hospital

Intensive care unit length of stay"through study completion, an average of 3 months".

the number of days a patient stays in the Intensive care unit

Patient survival and mortality"through study completion, an average of 1 year".

Measure ICU, RCC, and hospital mortality

Mechanical ventilation time"through study completion, an average of 3 months".

The number of days a patient requires mechanical ventilation

Respiratory care center stay"through study completion, an average of 3 months".

The number of days a patient stays in the respiratory care center

Secondary Outcome Measures
NameTimeMethod
PaO2 ratebaseline, day 1-14 of the study

patients PaO2 rate in ventilator

Kidney functionbaseline, day 1-14 of the study

Measured by blood urea nitrogen (BUN)

Number of days to reach 100% of target energy expenditure.baseline, day 1-14 of the study

Daily intake Number of days out of the first 14 days the patients reach100% of target energy expenditure.

Inspiratory airflow (V')baseline, day 1-14 of the study

Inspiratory airflow (V') in ventilator

Albuminbaseline, day 1-14 of the study

Albumin levels in blood sample

total proteinbaseline, day 1-14 of the study

total protein levels in blood sample

Creatinine (creatinine)baseline, day 1-14 of the study

Creatinine (creatinine) levels in blood sample

Daily urine outputbaseline, day 1-14 of the study

Daily urine output in ml

Number of days out of the first 14 days the patients reach 70% of their target energy expenditure.baseline, day 1-14 of the study

Daily intake Number of days out of the first 14 days the patients reach 70% of their target energy expenditure.

Oxygenation indexbaseline, day 1-14 of the study

FiO2 rate in ventilator

Number of days to reach 80% of target energy expenditure.baseline, day 1-14 of the study

Daily intake, number of days out of the first 14 days the patients reach 80% of target energy expenditure.

Respiratory rate (RR)baseline, day 1-14 of the study

Respiratory rate (RR) in ventilator

Respirator parametersbaseline, day 1-14 of the study

Tidal volume (VT) in ventilator

Positive end-expiratory pressure (PEEP)baseline, day 1-14 of the study

Positive end-expiratory pressure (PEEP) in ventilator

Alanine transaminase (ALT)baseline, day 1-14 of the study

Alanine transaminase (ALT) levels in blood sample

Liver functionbaseline, day 1-14 of the study

Aspartate transaminase (AST) levels in blood sample

Alkaline phosphatase (ALP),baseline, day 1-14 of the study

Alkaline phosphatase (ALP), levels in blood sample

Bilirubin,baseline, day 1-14 of the study

Bilirubin, levels in blood sample

L-lactate dehydrogenase (LD)baseline, day 1-14 of the study

L-lactate dehydrogenase (LD) levels in blood sample

use of vasopressors.baseline, day 1-14 of the study

Measured by use of vasopressors.

Prothrombin time (PT)baseline, day 1-14 of the study

Prothrombin time (PT)

Cardiovascular functionbaseline, day 1-14 of the study

Measured by blood pressure

Glasgow Coma Scale (GCS)baseline, day 1-14 of the study

Glasgow Coma Scale (GCS)

Trial Locations

Locations (1)

China Medical University Hospital

🇨🇳

Taichung, Taiwan

© Copyright 2025. All Rights Reserved by MedPath